Showing results (31-40 of 424) with videos related to
Sort By:
Pageof 43
Gastroenterology & Hepatology|February 3, 2012
Prognostic value of liver fibrosis biomarkers: a meta-analysisThierry Poynard, Yen Ngo, Hugo Perazzo, et al.The American Journal of Gastroenterology|June 15, 2006
Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?Dominique Thabut, Sophie Le Calvez, Vincent Thibault, et al.Journal of Hepatology|August 4, 2016
NAFLD and liver transplantation: Current burden and expected challengesRaluca Pais, A Sidney Barritt, Yvon Calmus, et al.Hepatology (Baltimore, Md.)|October 31, 2009
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trialVlad Ratziu, Fréderic Charlotte, Carole Bernhardt, et al.Plos One|August 8, 2015
Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic HepatitisMarika Rudler, Sarah Mouri, Frederic Charlotte, et al.Journal of Hepatology|December 11, 2017
A critical review of endpoints for non-cirrhotic NASH therapeutic trialsVlad RatziuNature Reviews. Gastroenterology & Hepatology|October 16, 2013
Pharmacological agents for NASHVlad RatziuLiver International : Official Journal of the International Association for the Study of the Liver|January 5, 2017
Non-pharmacological interventions in non-alcoholic fatty liver disease patientsVlad RatziuClinics and Research in Hepatology and Gastroenterology|November 13, 2012
Treatment of NASH with ursodeoxycholic acid: proVlad RatziuPageof 43